How Olema Pharmaceuticals (OLMA) Is Adding Pipeline Depth Behind Its Palazestrant Breast Cancer Bet

1 hour ago 3

Habib Ur Rehman

Wed, June 17, 2026 astatine 10:17 AM CDT 2 min read

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is 1 of the small-cap stocks with imaginable to emergence 1000 percent. The institution gave investors a caller pipeline marker connected May 21, erstwhile it reported archetypal Phase 1 objective information for OP-3136, its KAT6 inhibitor, astatine the 2026 ASCO Annual Meeting. Olema said OP-3136 monotherapy was well-tolerated, with nary dose-limiting toxicities observed and nary discontinuations owed to treatment-related adverse events, portion besides showing grounds of anti-tumor enactment crossed aggregate coagulated tumor types.

The update adds an earlier-stage plus down Olema's main palazestrant program, wherever the much contiguous valuation catalyst remains OPERA-01. In its May 12 first-quarter update, Olema said topline information from the Phase 3 OPERA-01 proceedings of palazestrant arsenic a monotherapy successful second- and third-line ER+/HER2- metastatic bosom crab are expected successful autumn 2026. The institution besides said its Phase 3 OPERA-02 proceedings of palazestrant successful operation with ribociclib successful frontline metastatic bosom crab continued to enroll patients. Olema ended the archetypal 4th with $505.3 cardinal successful cash, currency equivalents, and marketable securities.

How Olema Pharmaceuticals (OLMA) Is Adding Pipeline Depth Behind Its Palazestrant Breast Cancer Bet

How Olema Pharmaceuticals (OLMA) Is Adding Pipeline Depth Behind Its Palazestrant Breast Cancer Bet

Photo by National Cancer Institute connected Unsplash

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA), operating arsenic Olema Oncology, is simply a clinical-stage biopharmaceutical institution processing targeted therapies for bosom crab and different cancers.

While we admit the imaginable of OLMA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article